We have also confirmed an interim dividend of $0.93, reflecting the Board’s intention to increase the dividend to $2.90 for the full year of 2022. Looking across our business, we delivered revenue growth from all disease areas, reflecting not only the breadth of our portfolio, but also the...
Dividend Ideas Dividend Strategy Dividend Quick Picks Editors' Picks Analysis by Sector Energy Communication Services Real Estate Consumer Staples Tech Basic Materials Healthcare Consumer Utilities Financials Industrials Stock Comparison Tools FAANG Stocks Gold ETFs Cash Equivalents Big Bank Stocks Big Pharma...
Net debt increased by $1 billion to $24 billion, driven by the payment of the second interim dividend in March and $2.4 billion in deal payments, which include the second payment to Acerta made in the first quarter. As a reminder, we will pay the third and final payment in 2024. For ...
Dividend Quick Picks Editors' Picks Analysis by Sector Energy Communication Services Real Estate Consumer Staples Tech Basic Materials Healthcare Consumer Utilities Financials Industrials Stock Comparison Tools FAANG Stocks Gold ETFs Cash Equivalents Big Bank Stocks Big Pharma Stocks Retail Stocks Top Indexes...